Ascendis Pharma A/S (ASND)

NASDAQ: ASND · USD

$249

+3.49 (+1.4%)· Recorded snapshot

Market cap	16.4B
Revenue (ttm)	1.2B
Net income (ttm)	847.4M
EPS (ttm)	$13.4
Shares out	65.7M
P/E (trailing)	18.6x
P/E (forward)	37.1x
Volume	589,040
Beta	0.48

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.2B
Net income (ttm): 847.4M
EPS (ttm): $13.4
P/E (trailing): 18.6x
P/E (forward): 37.1x
Market cap: 16.4B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E37.1

P25 n/aP50 n/aP75 n/a

Trailing P/E18.6

P25 n/aP50 n/aP75 n/a

ROE118.8

P25 n/aP50 n/aP75 n/a

ROIC13

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ASND indicators

Market & fundamental data

Available fields

207

Groups with data

Currency

EUR

Showing 207 of 207 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001612042
Company name	Ascendis Pharma A/S
Country	Denmark
Country code	US
CUSIP number	K08588103
Earnings date	2026-11-11
Earnings time	amc
Employees	1,189
Employees change	172
Employees growth	16.91%
Enterprise value	$16B
Exchange	NASDAQ
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2006
Industry	Biotechnology
IPO date	2015-01-28
Is primary listing	Yes
Is SPAC	No
ISIN number	DK0060615755
Last 10-K release date	2026-02-11
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$16.4B
Market cap category	Large-Cap
Next earnings date	2026-11-11
Options	Yes
Price	$249.34
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	ASND
Website	https://ascendispharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	5.37%
EV/Earnings	18.78x
EV/EBIT	53.86x
EV/EBITDA	52.88x
EV/FCF	42.64x
EV/Sales	13.3x
FCF / EV yield	2.35%
FCF yield	2.29%
Forward EV/Sales	8.34x
Forward P/E	37.11x
Forward P/S	8.55x
Graham number	86.75148
Graham upside	-65.11%
P/(FCF - SBC) ratio	68.33x
P/(OCF - SBC) ratio	64.03x
P/B ratio	9.84x
P/E ratio	18.63x
P/FCF ratio	43.75x
P/OCF ratio	41.95x
P/S ratio	13.65x
Price / tangible book value	9.98x
Price/EBITDA ratio	54.25x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	24.7%
EBITDA margin	25.16%
FCF margin	32.01%
Gross margin	91.3%
Operating margin	24.7%
Pretax margin	9.34%
Profit margin	70.84%
Profit per employee	$712,727
Profitable quarters	2
Revenue per employee	$1M
ROA	9.58%
ROA (5Y)	-22.72%
ROCE	14.2%
ROE	118.78%
ROIC	12.98%
SBC / revenue	11.51%
Tax / revenue	-61.5%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (QoQ)	-71%
EPS growth quarters	8
EPS growth years	3
Gross profit growth	129.47%
Gross profit growth (Q)	146.15%
Gross profit growth 3Y	116.03%
Gross profit growth 5Y	49.94%
Net income growth (QoQ)	-67.11%
Net income growth quarters	9
Net income growth years	3
Revenue growth	113.35%
Revenue growth (Q)	114.68%
Revenue growth (QoQ)	37.58%
Revenue growth 10Y	66.26%
Revenue growth 3Y	106.35%
Revenue growth 5Y	190.52%
Revenue growth quarters	8
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-16M
Depreciation and amortization	$5.3M
EBIT	$295.5M
EBITDA	$301M
EPS	$13.38
FCF per share	$5.68
Financing cash flow	$-40.7M
Free cash flow	$373.3M
Free cash flow minus SBC	$239M
Gross profit	$1.1B
Income taxes	$-735.7M
Investing cash flow	$-14.9M
Net borrowing	$-33.6M
Net cash flow	$363.5M
Net income	$847.4M
Operating cash flow minus SBC	$255M
Operating income	$295.5M
Revenue	$1.2B
Stock-based compensation	$137.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	8.97
Book value per share	$24.99
Debt / EBITDA	1.63
Debt / equity	0.31
Debt / FCF	1.38
Interest coverage	2.01
Long-term assets	$1.1B
Long-term liabilities	$452.8M
Net cash (debt)	$413.8M
Net cash / market cap	2.53%
Net debt / EBITDA	-1.37
Net debt / equity	-0.25
Net debt / FCF	-1.11
Piotroski F-Score	7
Property, plant and equipment	$151.1M
Shareholders' equity	$1.6B
Tangible book value	$1.6B
Tangible book value per share	$24.93
Total assets	$2.6B
Total cash	$928M
Total debt	$514.2M
Total liabilities	$970.6M
WACC	7.39%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.62
Current assets	$1.5B
Current liabilities	$517.8M
Current ratio	2.99
Inventory turnover	0.3
Net working capital	$204.2M
Quick ratio	2.23
Working capital	$1.1B
Working capital turnover	2.54

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-6.52%
Dividend yield	0%
Shareholder yield	-6.52%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	1.42%
1M price change	10.4%
1M total return	10.4%
1W price change	6.29%
1W total return	6.29%
20-day SMA	$232.41
3M price change	-1.72%
3M total return	-1.72%
50-day SMA	$242.50
52-week high	$282.15
52-week high date	2026-07-09
52-week low	$203.80
52-week low date	2026-06-08
6M price change	9.88%
6M total return	9.88%
All-time high	$282.15
All-time high date	2026-07-09
All-time low	$203.80
All-time low date	2026-06-08
Average true range (ATR)	$6.38
Average volume	696.1K
Beta (1Y)	0.42
Beta (5Y)	0.49
Change from 52-week high	-11.63%
Change from 52-week low	22.35%
Change from all-time high	-11.73%
Change from all-time low	22.21%
Change from open	2.42%
Day's gap	-0.98%
Dollar volume	$146.9M
High price	$249.71
Low price	$243.45
Monthly RSI	0
Open price	$243.45
Position in 52-week range	94.09%
Premarket change	0.47%
Premarket close	$245.85
Premarket price	$247.00
Previous close	$245.85
Price vs 20-day SMA	7.16%
Price vs 50-day SMA	2.7%
Relative volume	0.85
RSI	64.43
Sharpe ratio	0.16
Sortino ratio	0.39
Volume	589K
Weekly RSI	53.22

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	65.6M
Float percentage	99.95%
Shares change (QoQ)	5.89%
Shares change (YoY)	6.52%
Shares held by insiders	0.02%
Shares held by institutions	80.62%
Shares outstanding	65.7M
Short % of shares	6.27%
Short ratio	3.9 days

Deeper analysis on ASND

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASND report

Is a complete ASND research report available?

No complete published report is available for Ascendis Pharma A/S (ASND) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Ascendis Pharma A/S (ASND)

Price

Financial snapshot

Fair-value bridge

Latest news · ASND

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASND indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASND

Frequently asked questions